Trial Profile
Efficacy of add on therapy of Vildagliptin versus Pioglitazone in inadequately controlled Type 2 Diabetes Mellitus patients on dual therapy of Metformin plus Sulfonylurea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Metformin; Sulfonylureas; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Jul 2013 New trial record